(Press-News.org) PHILADELPHIA -- Since their discovery in the 1950s, transfer RNAs (tRNAs) have been best known for their role in helping the cell make proteins from messenger RNA templates. However, recent studies have led to a previously-unsuspected concept that tRNAs are not always the end product; namely, they further serve as a source of small RNAs. Now researchers have discovered a new species of tRNA-derived small RNAs that are produced only in hormonally-driven breast and prostate cancers, and which contribute to cell proliferation. The results will be published online the week of June 29th in the Proceedings of the National Academy of Sciences (PNAS).
"In early RNA sequencing studies, researchers observed an abundance of tRNA fragments in cellular transcriptome but those fragments had often been disregarded as non-functional degradation products," says Yohei Kirino, Ph.D., assistant professor in the department of biochemistry and molecular biology and a researcher at the Computational Medicine Center at Thomas Jefferson University. "This research is one of several recent studies that bring to light a new role for tRNAs to produce small functional RNAs, in this case, functional tRNA halves."
Although other tRNA halves have been described before -- specifically those that are produced during a cellular stress response -- this discovery represents a new and distinct species of tRNA halves that the authors coined SHOT-RNAs, for sex hormone dependent tRNA-derived RNAs.
Kirino and colleagues discovered these tRNA halves while looking at germline-specific small RNAs in the cells of a silkworm (Bombyx mori). In the cells, the researchers accidentally detected the tRNA halves whose expression was linked to cell proliferation. Since proliferation is a hallmark of cancer cells, the researchers analyzed the involvement of tRNA halves in tumorigenesis.
Using a new TaqMan PCR-based technique, the researchers screened a number of cancer cell lines from various tissues, and discovered that tRNA halves were specifically expressed in large quantities in sex hormone-dependent cancers, i.e., estrogen receptor (ER)-positive breast cancer and androgen receptor (AR)-positive prostate cancer that are driven by the hormones estrogen and testosterone. After confirming the dependency of the tRNA halves' expression on the hormones and their receptors, they coined the new tRNA halves, SHOT-RNAs.
SHOT-RNAs contain a terminal modification which prevents their detection by standard RNA-seq method. "The modification makes SHOT-RNAs invisible in RNA-seq data and this could be the reason why SHOT-RNAs had not been discovered in spite of their abundance and clear expression specificity in hormone-dependent cancers," says Kirino.
Kirino and colleagues created a novel method called cP-RNA-seq to comprehensively sequence SHOT-RNAs and found that only eight tRNA species produce SHOT-RNAs. They were also able to track the molecule's function in the cells, and tease apart the other cellular players it interacted with. They discovered, for example, that SHOT-RNAs are created by an enzyme called Angiogenin whose activity is promoted by sex hormone signaling pathways. They also showed that SHOT-RNAs are involved in spurring cell proliferation.
"The SHOT-RNAs are an exciting development in the tRNA field," said Isidore Rigoutsos, Ph.D., director of the Computational Medicine Center at Thomas Jefferson University. "They are also another example of what appear to be regulators whose presence in a given tissue is modulated by a person's gender. Discovering such regulators is one of the major foci of the Computational Medicine Center."
In a final experiment, Kirino and colleagues also examined clinical samples from breast cancer patients and found elevated levels of SHOT-RNAs in patients with ER-positive luminal-type cancers, but not those that were negative for ER expression. The high expression specificity of SHOT-RNAs implies their potential use as a novel biomarker, and the next steps, says Kirino, are to explore relationships between SHOT-RNA expression and prognostic factors.
In spite of endocrine therapy to suppress hormone receptor activity or hormone exposure, many patients of hormone-dependent cancers encounter de novo or acquired resistance and require more aggressive treatments. Kirino says that "further studies to understand how SHOT-RNAs promote cell proliferation may lead to the use of SHOT-RNAs as potential target candidates for future therapeutic applications in breast and prostate cancers."
INFORMATION:
This study was supported in part by a NIH grant GM106047, a W. M. Keck Foundation grant, institutional funds, a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan #26293304, and a JSPS Postdoctoral Fellowships for Research Abroad.
For more information, contact Edyta Zielinska, 215-955-5291, edyta.zielinska@jefferson.edu.
About Jefferson -- Health is all we do.
Our newly formed organization, Jefferson, encompasses Jefferson Health and Thomas Jefferson University, representing our clinical and academic entities. Together, the people of Jefferson, 19,000 strong, provide the highest-quality, compassionate clinical care for patients, educate the health professionals of tomorrow, and discover new treatments and therapies that will define the future of health care.
Jefferson Health comprises five hospitals, 13 outpatient and urgent care centers, as well as physician practices and everywhere we deliver care throughout the city and suburbs across Philadelphia, Montgomery and Bucks Counties in Pa., and Camden County in New Jersey. Together, these facilities serve more than 78,000 inpatients, 238,000 emergency patients and 1.7 million outpatient visits annually. Thomas Jefferson University Hospital is the largest freestanding academic medical center in Philadelphia. Abington Hospital is the largest community teaching hospital in Montgomery or Bucks counties. Other hospitals include Jefferson Hospital for Neuroscience in Center City Philadelphia; Methodist Hospital in South Philadelphia; and Abington-Lansdale Hospital in Hatfield Township.
Thomas Jefferson University enrolls more than 3,900 future physicians, scientists, nurses and healthcare professionals in the Sidney Kimmel Medical College (SKMC); Jefferson Schools of Health Professions, Nursing, Pharmacy, Population Health; and the Graduate School of Biomedical Sciences, and is home of the National Cancer Institute (NCI)-designated Sidney Kimmel Cancer Center
For more information and a complete listing of Jefferson services and locations, visit http://www.jefferson.edu.
The warm temperature on a summer's day is often a time for relaxing, but researchers from the University of Leicester have suggested that a 'thermosensory' gene could be responsible for changes in behaviour in different climates.
The researchers from the University of Leicester's Department of Genetics have explored how the biological clock can be affected by the environment by examining the fruitfly Drosophila melanogaster, which shows 24 hour biological cycles and is used as a model organism for studies into human rhythms.
Like many humans, the fly has a 'siesta' ...
It's been difficult to explain patterns of toxic mercury in some parts of the world, such as why there's so much of the toxin deposited into ecosystems from the air in the southeastern United States, even upwind of usual sources.
A new analysis led by researchers at the University of Colorado Boulder shows that one key to understanding mercury's strange behavior may be the unexpected reactivity of naturally occurring halogen compounds from the ocean.
"Atmospheric chemistry involving bromine and iodine is turning out to be much more vigorous than we expected," said ...
A University of Oklahoma professor studying malaria mosquito interaction has discovered a new mosquito protein for the development of a new vaccine that is expected to stop the spread of the disease in areas where it is considered endemic. Malaria is transmitted by mosquitoes, and it infects millions of people in Africa, Asia and South America every year, causing a global health crisis. In addition to the local populations, U.S. military personnel stationed in these areas and travelers to these malaria-prone areas are at risk of becoming infected.
Jun Li, assistant ...
UC Santa Barbara geologist Jim Boles has found evidence of helium leakage from the Earth's mantle along a 30-mile stretch of the Newport-Inglewood Fault Zone in the Los Angeles Basin. Using samples of casing gas from two dozen oil wells ranging from LA's Westside to Newport Beach in Orange County, Boles discovered that more than one-third of the sites -- some of the deepest ones -- show evidence of high levels of helium-3 (3He).
Considered primordial, 3He is a vestige of the Big Bang. Its only terrestrial source is the mantle. Leakage of 3He suggests that the Newport-Inglewood ...
WASHINGTON (June 29, 2015) -The American College of Cardiology, Heart Rhythm Society and Society for Cardiovascular Angiography and Interventions today released a new overview on the implantation of left atrial appendage occlusion devices.
The implantation of left atrial appendage occlusion devices may lower the risk of stroke in patients with atrial fibrillation. As new devices are developed, it is anticipated that the use of left atrial appendage occlusion technologies in clinical practice will expand. The authors of the paper urge that the new technology should be ...
Stringing together meaningless sounds to create meaningful signals was previously thought to be the preserve of humans alone, but a new study, publishing June 29th in the Open Access journal PLOS Biology, has revealed that babbler birds are also able to communicate in this way.
Researchers at the Universities of Exeter and Zurich discovered that the chestnut-crowned babbler - a highly social bird found in the Australian Outback - has the ability to convey new meaning by rearranging the meaningless sounds in its calls. This babbler bird communication is reminiscent of ...
LAKEVILLE-MIDDLEBORO, Mass., (June 29, 2015) - A new study (1) reveals that drinking low-calorie cranberry juice cocktail may help lower the risk of chronic diseases that rank among the leading causes of death worldwide, including heart disease, diabetes and stroke. The finding is welcome news considering the World Health Organization estimates the trio of diseases annually claim 15.6 million lives around the globe (2). These illnesses are among the most common and costly health conditions, but fortunately, they are also among the most preventable through dietary intervention. ...
An overview and analysis of the factors underlying the recent Middle East Respiratory Syndrome coronavirus (MERS-CoV) outbreak in Korea has been published online ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
"On 20 May 2015, the Republic of Korea confirmed the first case of MERS-CoV infection in a 68 year old male who had returned to Seoul after traveling to 4 countries in the Middle East," write co-authors David S Hui, MD, of the Chinese University of Hong Kong, and Malik Peiris, DPhil, of the University ...
MAYWOOD, Ill. - At least 14 deaths of marathon runners, football players and other athletes have been attributed to a condition called exercise-associated hyponatremia, which results from drinking too much water or sports drinks.
But there's an easy way to prevent hyponatremia, according to new guidelines from an international expert panel: Simply put, drink only when you're thirsty.
"Using the innate thirst mechanism to guide fluid consumption is a strategy that should limit drinking in excess and developing hyponatremia while providing sufficient fluid to prevent ...
JACKSONVILLE, Fla. -- Clinicians testing the drug dasatinib, approved for several blood cancers, had hoped it would slow the aggressive growth of the deadly brain cancer glioblastoma; however, clinical trials to date have not found any benefit. Researchers at Mayo Clinic, who conducted one of those clinical trials, believe they know why dasatinib failed -- and what to do about it.
In the online issue of Molecular Oncology, investigators report finding that dasatinib inhibits proteins that promote cancer growth as expected but also suppresses proteins that protect against ...
